-
- Mar 23/25
Weekly reads: Chinese CRISPR biotechs, cultured meat war, MSCs for Alzheimer’s - Mar 22/25
Japanese scientists use stem cell treatment to restore movement in spinal injury patients - Mar 22/25
Study reveals key role of Treg cells in preventing autoimmune responses - Mar 21/25
Nursery of the blood: How stem cells calm the body’s immune response - Mar 21/25
Europe’s largest biotech fund exceeds target with €165m - Mar 20/25
Yale scientists develop advanced CRISPR tool to study complex genetic interactions - Mar 20/25
Revolutionary CRISPR technology offers enhanced precision for gene editing and optimized disease models - Mar 20/25
Regulatory T-cell therapy calms autoimmune response from gluten-sensitive T cells in mice - Mar 20/25
Can tissue engineering and regenerative medicine reverse spinal cord injuries? - Mar 20/25
2025 Killam Prizes awarded to Drs. Marco Marra and Peter Zandstra - Mar 20/25
Novartis reports Phase III efficacy and safety outcomes of SMA treatment - Mar 19/25
Breakthrough study unveils mechanics of DNA unwinding - Mar 19/25
Allogeneic cell therapies “poised for prime time” says expert - Mar 19/25
Cell therapy biotech Century Therapeutics axes cancer trial, turns to autoimmune - Mar 19/25
Manufacturing magic: Takeda and Autolus spill the beans on cell therapy production - Mar 18/25
Novel lentiviral vector advances gene therapy for rare neurological disease - Mar 18/25
Unique 3D printed bioresorbable implants for patient-specific bone repair - Mar 18/25
Arbor sails into rocky gene editing waters with $74M for rare liver disease therapy - Mar 18/25
CRISPR targets key cancer gene in Ewing sarcoma - Mar 18/25
Sarepta says teen died after its gene therapy treatment - Mar 17/25
BioSurfaces collaborates with Morphocell for innovation - Mar 17/25
Scientists gain insight into RNA-editing protein that could lead to improved treatment for cancer, autoimmune diseases - Mar 17/25
Cellular showdown: The battle for dominance in neighbourhood disputes - Mar 17/25
AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal - Mar 15/25
Can we reverse aging? Scientists uncover a key “zombie cell” pathway - Mar 13/25
MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup - Mar 13/25
Resurrected ancient enzyme could transform gene editing - Mar 13/25
CAR T-cell therapy cuts costs, reduces treatment in mantle cell lymphoma - Mar 13/25
European regulators warn about dangers of unregulated cell therapies - Mar 13/25
MIT engineers turn skin cells directly into neurons for cell therapy - Mar 13/25
AI’s next horizon: Cell and gene therapy manufacturing - Mar 12/25
CRISPR therapy eliminates 50 per cent of head and neck tumours in preclinical study - Mar 12/25
Specialized blood vessels and nitric oxide found to be key to stem cell survival and immune evasion - Mar 12/25
New tissue engineering strategies for spinal cord injury repair - Mar 12/25
Targeting calcium channels to stimulate cardiac regeneration - Mar 12/25
Canada’s Entos Pharmaceuticals plots $137M R&D, manufacturing hub in Edmonton - Mar 12/25
Preclinical study demonstrates improved gene therapy approach to treating a rare and devastating disease in children - Mar 11/25
‘The stage is set’ for next generation of CAR T cells in rheumatology - Mar 11/25
Breathing new life: Working toward an inhalable gene therapy for cystic fibrosis - Mar 11/25
Gene therapy shows promise for treating rare muscle disease - Mar 11/25
AWS and ElevateBio join forces to advance gene editing - Mar 11/25
Overcoming CAR T-cell therapy limitations - Mar 11/25
2seventy bio, Bluebird’s cell therapy spinout, sells to Bristol Myers for less than $300M - Mar 10/25
British scientists unveil world-leading technology to speed up drug discovery - Mar 10/25
Roche overhauls Spark gene therapy unit, recording $2.4B in full impairment - Mar 10/25
New stem cell-based vascular grafts could revolutionize cardiac surgery - Mar 10/25
Novel method to regenerate heart muscle offers hope for heart failure treatment - Mar 10/25
Protective ‘slime’ in the brain may help prevent aging and neurodegeneration - Mar 10/25
Beam gene therapy for protein deficiency passes early safety test, sets efficacy bar in space: analyst - Mar 10/25
Promising new CAR-T cell therapy targets challenging cancers - Mar 10/25
Stem cell therapy repairs cornea damage thought irreversible - Mar 9/25
Gene therapy in an implant: Neurotech lands first FDA approval in rare vision disorder - Mar 7/25
Hope for ALS and inflammatory diseases: Cellenkos’ CRANE technology breakthrough - Mar 7/25
New study explores Xolography for bioprinting of hydrogels in tissue engineering - Mar 6/25
Clinical trial tests novel stem-cell treatment for Parkinson’s disease
- Mar 23/25
